CompuNet Women’s Health Test Addition: Mycoplasma Genitalium

Premier Pulse     February 2023

CompuNet now offers testing to detect Mycoplasma genitalium (M. gen). This assay is a nucleic acid amplification test (NAAT) that enables efficient and reliable testing for M. gen RNA.

What Is Mycoplasma genitalium?

M. gen is a prevalent, often misdiagnosed STI. In fact, its prevalence is higher than gonorrhea and similar to chlamydia.1 M. gen is present in approximately 10.2% of women and 10.6% of men.2 If left untreated, M. gen infections can result in long-term health consequences, which include cervicitis, pelvic inflammatory disease, and urethritis in men.2

The addition of the M. gen test has resulted in the following three test options:

If you have any questions regarding the above testing, please contact Jessica Hutchinson, director of infectious disease testing, at (937) 297-8208 or or Ike Northern, system technical director of infectious diseases and microbiology, at (937) 297-8334 or

Article Reference

1 Getman D, et al. Mycoplasma genitalium prevalence, coinfection, and macrolide antibiotic resistance frequency in a multicenter clinical study cohort in the United States. J Clin Microbiol. 2016 Sep; 54(9): 2278-83

2 Gaydos C, et al. Molecular Testing for Mycoplasma genitalium in the United States: Results from the AMES Prospective Multicenter Clinical Study. J Clin Microbiol. 2019;57(11):e01125-19. Published 2019 Oct 23. doi:10.1128/JCM.01125-19

Back to the February 2023 issue of Premier Pulse

Premier Health Logo